Company Filing History:
Years Active: 2021
Title: Innovations of Ching-Shiang Chi in Genetic Research
Introduction
Ching-Shiang Chi is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of genetic research, particularly in the development of therapeutic methods for genetic disorders. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Ching-Shiang Chi holds a patent for an "Antisense oligonucleotide for splicing adjustment of mutant dopa decarboxylase gene and using method thereof." This invention discloses an antisense oligonucleotide that is complementary to SEQ ID NO: 1. The antisense oligonucleotide can modulate the alternative splicing site of the mutant dopa decarboxylase gene. This innovation is particularly beneficial for researching and developing drugs to treat AADC deficiency symptoms. Additionally, the patent outlines a method for using the antisense oligonucleotide in vitro.
Career Highlights
Ching-Shiang Chi is affiliated with Taichung Veterans General Hospital, where he applies his expertise in genetic research. His work has garnered attention for its potential impact on treating genetic disorders.
Collaborations
Ching-Shiang Chi collaborates with esteemed colleagues, including Chi-Ren Tsai and Hsiu-Fen Lee, who contribute to his research endeavors.
Conclusion
Ching-Shiang Chi's innovative work in genetic research exemplifies the potential of targeted therapies in addressing genetic disorders. His contributions are paving the way for advancements in medical treatments.